Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • Telephone

      • +972-77-2005042 from 8 AM - 11 PM IL

      • Contact
      • Contact

        +972-77-2005042
        from 8 AM - 11 PM IL

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Request More Information
      • Journalists
      • GDPR

      Game-Changing Wrinkle Reduction Device Receives Key Regulatory Clearance in Canada

      Sofwave_Logo

      News provided by

      Sofwave

      24 Feb, 2021, 19:00 IST

      Share this article

      Share this article


      Sofwave is crucial to your aesthetic practice. Learn Why!

      YOQNEAM, Israel, Feb. 24, 2021 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received clearance from Health Canada for its next-generation Sofwave system. Aesthetic practices adding Sofwave to their service menu will be able to offer a noticeable wrinkle reduction in a single treatment through the industry's most innovative energy-based treatment.

      According to Sharyn A Laughlin M.D., a leading expert in the field of dermatology and Medical Director of Laserderm, this new device meets an unmet need. "  "Using Sofwave I can give my patients impressive results in one treatment session." 

      "Sofwave has been the most anticipated introduction of non-invasive aesthetic devices since its introduction and rapid adoption in the US," said Jay Herman, President of Salient Medical.  "We are excited to partner with Sofwave and be able to provide this opportunity to physicians across Canada to enhance their practice."

      Louis Scafuri, Chief Executive Officer of Sofwave Medical, calls the clearance for Sofwave technology "an important milestone for the company," adding that the new technology "targets a growing customer base of patients who are looking to reduce their wrinkles and facial lines with non-invasive technology."

      Sofwave's state-of-the-art Synchronous Ultrasound Parallel Beam technology SUPERBTM addresses the growing demand for non-invasive treatments that deliver noticeable wrinkle reduction. The device's seven cooled transducers are directly coupled to the epidermis, creating a unique 3D array of volumetric thermal zones that deliver parallel energy simultaneously, resulting in significant collagen remodeling in the mid-dermis. A single Sofwave treatment reduces facial wrinkles in a fast 30 to 45minute non-invasive treatment with minimal downtime or post-treatment discomfort.

      ABOUT SOFWAVE MEDICAL LTD.
      Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction using proprietary breakthrough technology. Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients.

      Logo - https://mma.prnewswire.com/media/1224110/Sofwave_Logo.jpg  

      Modal title

      Contact PR Newswire

      • +972-77-2005042
        from 8 AM - 11 PM IL

      Global Sites

      • APAC
      • APAC - Traditional Chinese
      • Asia
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany

       

      • India
      • Indonesia
      • Israel
      • Italy
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland

       

      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • United States

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921
      Global Sites
      • Asia
      • Brazil
      • Canada
      • Csezh
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Israel
      • Italie
      • Mexico
      • Middle East
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • United States
      +972-77-2005042
      from 8 AM - 11 PM IL
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • Cookie Settings
      Copyright © 2026 Cision US Inc.